|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current assets: | |||||||||||||||||||
| Cash | |||||||||||||||||||
| Cash, restricted cash, and cash equivalents | |||||||||||||||||||
| Other receivables | |||||||||||||||||||
| Prepaid expenses and other current assets | |||||||||||||||||||
| Money market funds held in Trust Account | |||||||||||||||||||
| Investment in equity securities, at cost | |||||||||||||||||||
| Deferred offering costs | |||||||||||||||||||
| Total current assets | |||||||||||||||||||
| Investments held in Trust Account | |||||||||||||||||||
| Deferred offering costs, net of current portion | |||||||||||||||||||
| Operating lease right-of-use asset | |||||||||||||||||||
| Property and equipment, net | |||||||||||||||||||
| Total assets | |||||||||||||||||||
| Current liabilities: | |||||||||||||||||||
| Accounts payable and accrued expenses | |||||||||||||||||||
| Income tax payable | |||||||||||||||||||
| Working capital loan – related party | |||||||||||||||||||
| Related Party | |||||||||||||||||||
| Total working capital loan – related party | |||||||||||||||||||
| Franchise tax payable | |||||||||||||||||||
| Excise tax payable | |||||||||||||||||||
| Due to Affiliate | |||||||||||||||||||
| Convertible notes payable, net | |||||||||||||||||||
| Accounts payable | |||||||||||||||||||
| Accrued liabilities | |||||||||||||||||||
| Common stock subscription deposit | |||||||||||||||||||
| Insurance payable | |||||||||||||||||||
| Operating lease liability | |||||||||||||||||||
| Short-term notes payable, net | |||||||||||||||||||
| Preferred stock liabilities | |||||||||||||||||||
| Series Seed Convertible Preferred Stock | |||||||||||||||||||
| Series A | |||||||||||||||||||
| Series D Convertible Preferred Stock | |||||||||||||||||||
| Series E Convertible Preferred Stock | |||||||||||||||||||
| Total preferred stock liabilities | |||||||||||||||||||
| Convertible preferred stock | |||||||||||||||||||
| Series Seed Convertible Preferred Stock | |||||||||||||||||||
| Series A | |||||||||||||||||||
| Total convertible preferred stock | |||||||||||||||||||
| Derivative liabilities - convertible notes | |||||||||||||||||||
| Earnout liability | |||||||||||||||||||
| Preferred stock warrant liability | |||||||||||||||||||
| Deemed dividend – common stock liability, 692 shares | |||||||||||||||||||
| Total current liabilities | |||||||||||||||||||
| Deferred underwriting fee payable | |||||||||||||||||||
| Advance from shareholder | |||||||||||||||||||
| Operating lease liability, net of current portion | |||||||||||||||||||
| Convertible notes payable, net | |||||||||||||||||||
| Total liabilities | |||||||||||||||||||
| Stockholders’ deficit: | |||||||||||||||||||
| Preferred Stock Value | |||||||||||||||||||
| Series D Convertible Preferred Stock | |||||||||||||||||||
| Series E Convertible Preferred Stock | |||||||||||||||||||
| Series C Convertible Preferred Stock | |||||||||||||||||||
| Series A Convertible Preferred Stock | |||||||||||||||||||
| Series B Convertible Preferred Stock | |||||||||||||||||||
| Class A common stock; $0.0001 par value; 1,000,000,000 shares authorized; 63,811,396 and 21,102,671 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | |||||||||||||||||||
| Class A Common Stock | |||||||||||||||||||
| Total class A common stock; $0.0001 par value; 1,000,000,000 shares authorized; 63,811,396 and 21,102,671 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | |||||||||||||||||||
| Additional paid-in capital | |||||||||||||||||||
| Stock subscription receivable | |||||||||||||||||||
| Accumulated deficit | |||||||||||||||||||
| Total stockholders’ deficit | |||||||||||||||||||
| Total liabilities and stockholders’ deficit | |||||||||||||||||||
Loading...